胎児モニタリングの世界市場規模：地域別、範囲および予測

胎児モニタリングの市場規模と予測

胎児モニタリング市場規模は、2023年に25億米ドルと評価され、2024年から2030年にかけてCAGR 6.1%で成長し、2030年には102億3,000万米ドルに達すると予測されます。妊婦の意識の高まりが胎児モニタリングシステムの成長を促進しています。胎児モニタリングシステム市場は、避妊方法の改善やリスクの低減に利用できるリアルタイムのモニタリングデータへの要望もあって拡大しています。より良いヘルスケア施設のための政府のイニシアチブの増加と民間企業からの投資は、市場の成長をさらに促進しています。世界の胎児モニタリング市場レポートは市場の全体的な評価を提供します。主要セグメント、動向、市場促進要因、競合情勢、市場で重要な役割を果たしている要因などを包括的に分析しています。

世界の胎児モニタリング市場の定義

胎児の動きや心拍数、母体の収縮をモニターするために使用される診断ツールは、胎児モニタリングシステムとして知られています。これは、陣痛中の子宮収縮をモニターするために使用される基本的な装置です。主に胎児の健康と陣痛の進行をモニターします。医学用語では、安全な出産を確実にするために胎児の健康をチェックする医学的方法と呼ばれています。また、黄疸、精神遅滞、新生児の病気、低体温、視覚や聴覚の問題、慢性肺疾患などを把握するためにも使用されます。陣痛中や妊娠中、医師は胎児の心拍を確認し、胎児の健康状態を監視します。これは、陣痛や妊娠中にヘルスケアプロバイダーが採用する非常に一般的な手順です。

モニタリングには2つの方法があります。1つ目は、音波とコンピュータを使用する胎児鏡と呼ばれる特別な道具を必要とする外部モニタリングです。もうひとつは内部モニタリングで、女性の子宮内にいる赤ちゃんの頭に小さな電極をつける必要があります。これらのシステムから得られる情報により、ヘルスケア提供者は出産プロセスに介入するか否かのアイデアを得ることができます。

世界の胎児モニタリング市場概要

胎児モニタリングシステムの人気は、妊婦の意識が高まるにつれて高まっています。世界中のメーカーがテクノロジーを活用して低価格の新製品を開発し、BMIの高い妊婦の間でこれらの製品の認知度を高めています。より良い出産管理とリスク低減のためのリアルタイムのモニタリングデータに対する需要も、胎児モニタリング市場の成長に寄与しています。より良いヘルスケア施設のための政府のイニシアチブの増加と民間企業からの投資が市場の成長を促進しています。

予測期間中、胎児モニタリング市場は拡大が見込まれています。心肺疾患の開発、非侵襲的手術などの技術進歩、母体と胎児の健康のための世界の政府・非政府イニシアチブの増加、胎児モニタリングの開発に対するメーカーの意識と投資意欲の高まり、妊娠後期、多胎妊娠、早産症例の増加などは、胎児モニタリングの世界市場を牽引しているいくつかの要因です。胎児心拍数、胎動、子宮収縮を評価する装置がこの市場に含まれます。

妊娠中の胎児モニタリングの需要の増加は市場成長を促進すると予想されます。技術の進歩と早産や出生率の急増は、今後の世界市場の成長を促進すると予想されます。世界市場は、出血率の上昇、早産率の上昇、胎児モニタリングサプリメントの必要性によってさらに押し上げられます。さらに、ポータブルでワイヤレスな製品や技術の出現、未開拓の新興国は、世界的に有利な成長機会を提供しています。反対に、世界の胎児モニタリング市場は、厳しい規制要件、低い出生率、高価な機器によって制約を受けています。胎児モニタリング機器の高コストは、低所得国や低資源病院にとっては困難であるため、この市場の成長を抑制する可能性があります。しかし、ワイヤレス胎児モニタリングシステムに関連する高コスト、製品の標準以下の品質、厳しい政府の規制プロセスは、胎児モニタリング市場の成長を妨げる可能性があります。

目次

第1章 世界の胎児モニタリング市場のイントロダクション

• 市場概要
• 調査範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 胎児モニタリングの世界市場展望

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析
• 規制の枠組み

第5章 胎児モニタリングの世界市場：方法別

• 概要
• 侵襲的
• 非侵襲性

第6章 胎児モニタリングの世界市場：ポータビリティ別

• 概要
• 非携帯型システム
• 携帯型システム

第7章 胎児モニタリングの世界市場：エンドユーザー別

• 概要
• 病院
• 診療所
• その他

第8章 胎児モニタリングの世界市場：用途別

• 概要
• 分娩前胎児モニタリング
• 分娩時胎児モニタリング

第9章 胎児モニタリングの世界市場：製品別

• 概要
• 機器・消耗品
  • 超音波
  • 電子母体/胎児モニター
  • 胎児電極
  • 胎児ドップラー
  • 子宮収縮モニター
  • 遠隔測定ソリューション
  • アクセサリーと消耗品
  • その他の製品
• ソフトウェア

第10章 胎児モニタリングの世界市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 世界のその他の地域

第11章 世界の胎児モニタリング市場：競合情勢

• 概要
• 企業市場シェア
• ベンダー情勢
• 主な発展戦略

第12章 企業プロファイル

• Analogic Corporation
• Fujifilm Sonosite, Inc.
• GE Healthcare
• Philips Healthcare
• Siemens Healthcare
• Covidien PLC
• Arjohuntleigh
• Neoventa Medical AB
• Natus Medical Incorporated
• Spacelabs Healthcare

第13章 付録

• 関連レポート

Fetal Monitoring Market Size And Forecast

Fetal Monitoring Market size was valued at USD 2.5 Billion in 2023 and is projected to reach USD 10.23 Billion by 2030 , growing at a CAGR of 6.1% from 2024 to 2030. Rising awareness among pregnant women is fuelling the growth of Fetal Monitoring Systems. The market for Fetal Monitoring systems is expanding in part because of the desire for real-time monitoring data that can be used to improve birth control methods and lower risks. Increasing government initiatives for better healthcare facilities and investment from private firms are further driving the growth of the market. The Global Fetal Monitoring Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Fetal Monitoring Market Definition

A diagnostic tool used to monitor the movement and heart rate of the foetus and maternal contractions is known as a Fetal Monitoring system. It is a fundamental device that is used for monitoring uterine contractions during labor. It mainly monitors well-being of the foetus and progress of labor. In medical terms, it is referred to as a medical method to check the health of an unborn baby to ensure a safe birth. It is also used to keep track of jaundice, mental retardation, newborn illnesses, hypothermia, visual and hearing issues, and chronic lung ailments. During labor and in pregnancy, the doctor checks the heartbeat of the baby to monitor the health of the unborn foetus. It is a very common procedure adopted by healthcare providers during labor and pregnancy.

There are two ways to do the monitoring. First is the external monitoring that requires a special tool called fetoscope that uses sound waves and computers. The second way of monitoring is internal monitoring that requires putting a small electrode on the baby's head while he or she is in a female uterus. The information obtained from these systems gives the healthcare provider the idea to intervene in the birth process or not.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Fetal Monitoring Market Overview

The popularity of Fetal Monitoring systems is increasing as pregnant women become more aware of them. Manufacturers around the world are leveraging the use of technology to innovate new products that are low in cost, also they are promoting the awareness of these products among high BMI pregnant women. The demand for real-time monitoring data for better birth control and reduced risks is also contributing to the growth of the Fetal Monitoring Market. Increasing government initiatives for better healthcare facilities and investment from private firms are driving the growth of the market.

Over the projected period, the market for Fetal Monitoring is anticipated to expand. Growing prevalence of cardiopulmonary diseases, technological advancement such as noninvasive surgeries, increasing government and non-government initiatives for maternal & fetal health over the world, rising manufacturer's awareness & willingness to invest in the development of Fetal Monitoring, and an increase in the number of post-term pregnancy, multiple pregnancies, and premature delivery cases, are few factors that are driving the global Fetal Monitoring market. Devices for evaluating fetal heart rate, fetal movement, and uterine contractions are included in this market.

An increase in the demand for Fetal Monitoring during pregnancy is anticipated to drive market growth. The technological advancements and surge in preterm births and birth rates are expected to propel the global market growth in the future. The global market is further boosted by the rise in hemorrhage rates, preterm birth rates, and the need for Fetal Monitoring supplements. Moreover, the emergence of portable and wireless products and technologies and untapped emerging economies provide lucrative growth opportunities globally. Contrarily, the worldwide Fetal Monitoring market is constrained by strict regulatory requirements, low birth rates, and expensive equipment. The high costs of Fetal Monitoring equipment can be challenging to low-income nations and low-resource hospitals, thus restraining this market's growth. Though, the high costs associated with wireless Fetal Monitoring Systems, the substandard quality of the products, and the stringent government regulatory process may hamper the growth of the Fetal Monitoring Market

Global Fetal Monitoring Market: Segmentation Analysis

The Global Fetal Monitoring Market is segmented on the basis of Raw Material, Method, End User, Application, And Geography.

Fetal Monitoring Market, By Raw Material

• Instruments & Consumables
• Ultrasound & Ultrasonography
• Electronic Fetal Monitoring
• Fetal Electrodes
• Fetal Doppler
• Uterine Contraction Monitor
• Telemetry Solutions
• Accessories & Consumables
• Software
• Other Products

Based on Raw Material, the market is segmented into Instruments & Consumables, Ultrasound & Ultrasonography, Electronic Fetal Monitoring, Fetal Electrodes, Fetal Doppler, Uterine Contraction Monitor, Telemetry Solutions, Accessories & Consumables, Software, and Other Products. Ultrasound devices are the largest segment in this market. This segment's growth can primarily be attributed to technological advancements, increasing congenital anomalies, maternal mortality, and rising regulatory approvals.

Fetal Monitoring Market, By Method

• Invasive
• Non-invasive

Based on Method, the market is segmented into Invasive, Non-invasive. The noninvasive held the majority of the market share. Particularly in high-risk pregnancies, noninvasive technologies are widely regarded for their safer manner of identifying and monitoring the baby. The expansion of this market is driven by the increasing approvals of different noninvasive monitoring devices and emerging sophisticated technologies.

Fetal Monitoring Market, By End User

• Hospitals
• Clinics
• Others

Based on End-user, The Market is Segmented into Hospitals, Clinics, and Others. Hospitals accounted for the largest share of this market. This segment's growth can be attributed to several factors, such as highly advanced facilities in hospitals and the increasing number of pregnancy procedures. Technological advancements, coupled with government funding, are also encouraging the installation of new tools and devices in hospitals, thus supporting market growth.

Fetal Monitoring Market, By Application

• Antepartum Fetal Monitoring
• Intrapartum Fetal Monitoring

Based on Application, The market is divided into Intrapartum Foetal Monitoring and Antepartum Foetal Monitoring. The market for Fetal Monitoring is dominated by the antepartum sector. For the purpose of diagnosing any congenital fetal anomalies, antepartum Fetal Monitoring is done during the whole gestation period. The antepartum category is expanding as a result of intensive monitoring protocols, recent product introductions, an increasing occurrence of fetal abnormalities, and maternal fatalities.

Fetal Monitoring Market, By Geography

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
• On the basis of Geography, the global Fetal Monitoring Market is classified into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Based on geography, during the projected period, North America is anticipated to account for the biggest market share. Due to a rising trend of motor vehicle manufacturers that are rebounding and a favorable environment for fixed investment in the region, the United States currently holds the top spot in the market.

Key Players

• The "Global Fetal Monitoring Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as
• Analogic Corporation, ArjoHuntleigh Inc., Covidien PLC, FUJIFILM SonoSite, Inc., GE Healthcare, Natus Medical Incorporated, Neoventa Medical, Philips Healthcare, Siemens Healthcare, Spacelabs Healthcare Inc. and Others.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• In April 2019, The U.S. Medical business OF Henry Schein, and MindChild Medical, Inc. announced a collaboration with an exclusive distribution and supply agreement for the MERIDIANTM M110 Fetal Monitoring System.
• In April 2021, PeriGen, Inc., the leading company in implementing artificial intelligence (AI) to help enhance childbirth safety, announced that it has been acquired by Halma plc.
• In April 2017, GE Healthcare acquired Monica Healthcare, a producer of wireless Fetal Monitoring technology UK-based, to develop its digital maternal-infant care business. The acquisition's financial terms were not revealed.
• In June 2020, Philips launched the Avalon CL Fetal and Maternal Pod and Patch in the United States to enable and maternal and Fetal Monitoring. This machine allows the constant, non-invasive monitoring of maternal heart rate, fetal heart rate, and uterine behavior by arranging the single-use, 48-hour, disposable electrode patch on the mother's abdomen.
• In June 2021, The Nuvo Group received FDA approval for the augmented utility of its INVU, a prescription-initiated remote pregnancy monitoring platform, with the introduction of a new uterine activity component that allows remote monitoring of uterine action.
• Ace Matrix Analysis
• The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as
• Active, Cutting Edge, Emerging, and Innovators.
• Market Attractiveness
• The image of market attractiveness provided would further help to get information about the region that is majorly leading in the global Fetal Monitoring market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.
• Porter's Five Forces
• The image provided would further help to get information about Porter's five forces framework providing a blueprint for understanding the behavior of competitors and a player's strategic positioning in the respective industry. Porter's five forces model can be used to assess the competitive landscape in the global Fetal Monitoring market, gauge the attractiveness of a certain sector, and assess investment possibilities.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL FETAL MONITORING MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL FETAL MONITORING MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis
• 4.5 Regulatory Framework

5 GLOBAL FETAL MONITORING MARKET, BY METHOD

• 5.1 Overview
• 5.2 Invasive
• 5.3 Non-Invasive

6 GLOBAL FETAL MONITORING MARKET, BY PORTABILITY

• 6.1 Overview
• 6.2 Non-Portable Systems
• 6.3 Portable Systems

7 GLOBAL FETAL MONITORING MARKET, BY END USER

• 7.1 Overview
• 7.2 Hospitals
• 7.3 Clinics
• 7.4 Others

8 GLOBAL FETAL MONITORING MARKET, BY APPLICATION

• 8.1 Overview
• 8.2 Antepartum Fetal Monitoring
• 8.3 Intrapartum Fetal Monitoring

9 GLOBAL FETAL MONITORING MARKET, BY PRODUCT

• 9.1 Overview
• 9.2 Instruments & Consumables
  • 9.2.1 Ultrasound
  • 9.2.1.1 2d Ultrasound
  • 9.2.1.2 3d & 4d Ultrasound
  • 9.2.1.3 Doppler Imaging
  • 9.2.2 Electronic Maternal/Fetal Monitor
  • 9.2.2.1 External Monitor
  • 9.2.2.2 Other Monitors
  • 9.2.3 Fetal Electrodes
  • 9.2.4 Fetal Doppler
  • 9.2.5 Uterine Contraction Monitor
  • 9.2.5.1 External Monitoring
  • 9.2.5.2 Internal Monitoring
  • 9.2.6 Telemetry Solutions
  • 9.2.7 Accessories & Consumables
  • 9.2.8 Other Products
• 9.3 Software

10 GLOBAL FETAL MONITORING MARKET, BY GEOGRAPHY

• 10.1 Overview
• 10.2 North America
  • 10.2.1 U.S.
  • 10.2.2 Canada
  • 10.2.3 Mexico
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 U.K.
  • 10.3.3 France
  • 10.3.4 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 China
  • 10.4.2 Japan
  • 10.4.3 India
  • 10.4.4 Rest of Asia Pacific
• 10.5 Latin America
  • 10.5.1 Brazil
  • 10.5.2 Argentina
• 10.6 Rest of the World

11 GLOBAL FETAL MONITORING MARKET COMPETITIVE LANDSCAPE

• 11.1 Overview
• 11.2 Company Market Share
• 11.3 Vendor Landscape
• 11.4 Key Development Strategies

12 COMPANY PROFILES

• 12.1 Analogic Corporation
  • 12.1.1 Overview
  • 12.1.2 Financial Performance
  • 12.1.3 Product Outlook
  • 12.1.4 Key Developments
• 12.2 Fujifilm Sonosite, Inc.
  • 12.2.1 Overview
  • 12.2.2 Financial Performance
  • 12.2.3 Product Outlook
  • 12.2.4 Key Developments
• 12.3 GE Healthcare
  • 12.3.1 Overview
  • 12.3.2 Financial Performance
  • 12.3.3 Product Outlook
  • 12.3.4 Key Developments
• 12.4 Philips Healthcare
  • 12.4.1 Overview
  • 12.4.2 Financial Performance
  • 12.4.3 Product Outlook
  • 12.4.4 Key Developments
• 12.5 Siemens Healthcare
  • 12.5.1 Overview
  • 12.5.2 Financial Performance
  • 12.5.3 Product Outlook
  • 12.5.4 Key Developments
• 12.6 Covidien PLC
  • 12.6.1 Overview
  • 12.6.2 Financial Performance
  • 12.6.3 Product Outlook
  • 12.6.4 Key Developments
• 12.7 Arjohuntleigh
  • 12.7.1 Overview
  • 12.7.2 Financial Performance
  • 12.7.3 Product Outlook
  • 12.7.4 Key Developments
• 12.8 Neoventa Medical AB
  • 12.8.1 Overview
  • 12.8.2 Financial Performance
  • 12.8.3 Product Outlook
  • 12.8.4 Key Developments
• 12.9 Natus Medical Incorporated
  • 12.9.1 Overview
  • 12.9.2 Financial Performance
  • 12.9.3 Product Outlook
  • 12.9.4 Key Developments
• 12.10 Spacelabs Healthcare
  • 12.10.1 Overview
  • 12.10.2 Financial Performance
  • 12.10.3 Product Outlook
  • 12.10.4 Key Developments

13 Appendix

• 13.1 Related Reports